All Curated Mutation Sites in HPV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
E1
  
E1^E4
  
E2
  
E5
  
E6
  
E7
  
L1
  
L2
  

Keyword: Squamous Intraepithelial Lesions-31670402
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 31670402 G6329T
LCR
Squamous Intraepithelial Lesions
G
R
C
L
View
2 31670402 G6657A
LCR
Squamous Intraepithelial Lesions
G
R
C
L
View
3 31670402 A7689G
E7
E7
Squamous Intraepithelial Lesions
G
R
C
L
View
4 31670402 N29H
E7
E7
Squamous Intraepithelial Lesions
G
R
C
L
View
5 31670402 N29S
E7
E7
Squamous Intraepithelial Lesions
G
R
C
L
View
6 31670402 R77C
E7
E7
Squamous Intraepithelial Lesions
G
R
C
L
View
7 31670402 D32E
E6
E6
Squamous Intraepithelial Lesions
G
R
C
L
View
8 31670402 D32N
E6
E6
Squamous Intraepithelial Lesions
G
R
C
L
View
9 31670402 E120D
E6
E6
Squamous Intraepithelial Lesions
G
R
C
L
View
10 31670402 E36Q
E6
E6
Squamous Intraepithelial Lesions
G
R
C
L
View
11 31670402 H85Y
E6
E6
Squamous Intraepithelial Lesions
G
R
C
L
View
12 31670402 I34L
E6
E6
Squamous Intraepithelial Lesions
G
R
C
L
View
13 31670402 L90V
E6
E6
Squamous Intraepithelial Lesions
G
R
C
L
View
14 31670402 R5G
E6
E6
Squamous Intraepithelial Lesions
G
R
C
L
View
15 31670402 T7220G
E6
E6
Squamous Intraepithelial Lesions
G
R
C
L
View
Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.